Literature DB >> 28229612

Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain.

Mauricio Iribarren Díaz1, Antonio Ocampo Hermida2, Joaquín González-Carreró Fojón3, Rebeca Longueira Suárez2, Alberto Rivera Gallego2, Enrique Casal Núñez4, Antón Ocampo Álvarez5, Edward R Cachay6.   

Abstract

BACKGROUND: Men who have sex with men (MSM) infected with human immunodeficiency virus (HIV) have the highest risk of developing anal cancer (AC). The objective of this study was to describe our screening implementation program in this population, and report the prevalence of human papillomavirus (HPV) anal infection, and cytological and histological findings in a Spanish medium-size community (Vigo, Spain).
METHOD: Prospective cohort analysis of 240 HIV-infected MSM. Cellular anal sample and high risk HPV (HR-HPV)-tests were performed to study cytological changes and HPV genotyping. High resolution anoscopy (HRA) was performed in 209 patients. Results were analyzed with respect to epidemiological, clinical and analytical factors.
RESULTS: Of 209 patients selected for HRA, the prevalence of HR-HPV anal infection, cytological and histological alterations was 85.6%, 47.5%, and 39.8%, respectively. Sensitivity and specificity for ≥ ASCUS (atypia of squamous cells of undetermined significance) cytology in relation to histological alterations were 61% and 85%, (OR: 8.7; IC 95%: 4.4-17.2), respectively. Observed concordance between high-grade squamous intraepithelial lesion (HSIL) cytology and HSIL anal intraepithelial neoplasia types 2 and 3 (AIN-2/3) histology was 64% (OR: 11.4; IC 95%: 3.6-36.7). One patient with HSIL cytology presented a prevalent anal squamous carcinoma.
CONCLUSIONS: HRA was feasible with similar results to relevant groups. There was a high prevalence of anal HR-HPV infection, and cytological and histological alterations.

Entities:  

Mesh:

Year:  2017        PMID: 28229612     DOI: 10.17235/reed.2017.4274/2016

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  3 in total

1.  Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

Authors:  L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

2.  High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298.

Authors:  Ross D Cranston; Michelle S Cespedes; Pawel Paczuski; Ming Yang; Robert W Coombs; Joan Dragavon; Alfred Saah; Catherine Godfrey; Jennifer Y Webster-Cyriaque; Elizabeth Y Chiao; Barbara Bastow; Timothy Wilkin
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 2.830

3.  Anal HPV infection and correlates in HIV-infected patients attending a Sexually Transmitted Infection clinic in Brazil.

Authors:  Neide Aparecida Tosato Boldrini; Lays Paula Bondi Volpini; Luciana Bueno de Freitas; Carlos Musso; Paulo Roberto Merçon de Vargas; Liliana Cruz Spano; Angelica Espinosa Miranda
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.